nicotine has been researched along with oxidopamine in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (11.54) | 18.7374 |
| 1990's | 16 (30.77) | 18.2507 |
| 2000's | 21 (40.38) | 29.6817 |
| 2010's | 8 (15.38) | 24.3611 |
| 2020's | 1 (1.92) | 2.80 |
| Authors | Studies |
|---|---|
| Matta, SG; Sharp, BM | 1 |
| Clarke, PB; Coen, KM; Corrigall, WA; Franklin, KB | 1 |
| Kiss, J; Lajtha, A; Sandor, NT; Sershen, H; Torocsik, A; Vizi, ES; Zelles, T | 1 |
| Abrous, N; Aunis, D; Decombe, R; Herman, JP; Peschanski, M; Rivot, JP | 1 |
| Brazell, MP; Gray, JA; Mitchell, SN; Schugens, MM | 1 |
| Matta, SG; Sharp, BM; Singh, J | 1 |
| Koley, B; Koley, J; Saha, JK | 1 |
| Beleslin, DB; Krstić, SK | 1 |
| Krstić, MK | 1 |
| Koley, BN; Koley, J; Saha, JK | 1 |
| Al-Humayyd, M; White, TD | 1 |
| Kigoshi, S; Muramatsu, I; Oshita, M | 1 |
| Back, SM; Hua, XY; Jinno, S; Tam, EK; Yaksh, TL | 1 |
| Glowinski, J; Hervé, D; Tassin, JP; Vezina, P | 1 |
| Gray, JA; Grigoryan, G; Hodges, H; Mitchell, S; Sinden, JD | 1 |
| Agnati, LF; Andersson, K; Belluardo, N; Blum, M; Fuxe, K; Mudó, G; Wu, G | 1 |
| Gomita, Y; Kawasaki, H; Oishi, R; Suemaru, K; Tanizaki, Y | 1 |
| Cui, WY; Gao, ZG; Liu, CG | 1 |
| Edvinsson, L; Lee, TJ; Zhang, W | 1 |
| Araki, H; Gomita, Y; Kawakami, Y; Suemaru, K; Tanizaki, Y | 1 |
| Clarke, PB; Louis, M | 1 |
| Ferrari, AU; Marano, G; Mori, I; Ramirez, A | 1 |
| Berger, SP; Fox, L; Ho, LB; Reid, MS | 1 |
| Abin-Carriquiry, JA; Costa, G; Dajas, F | 1 |
| Boye, SM; Clarke, PB; Grant, RJ | 1 |
| Abín-Carriquiry, JA; Costa, G; Dajas, F; McGregor, R; Urbanavicius, J | 1 |
| Kamel, D; Kay, TS; Krentz, L; Meshul, CK; Moore, C | 1 |
| Hermida-Ameijeiras, A; Labandeira-García, JL; López-Real, AM; Méndez-Alvarez, E; Soto-Otero, R | 1 |
| Bardo, MT; Brown, RW; Dwoskin, LP; Green, TA; Phillips, SB | 1 |
| Ahtee, L; Janhunen, S; Tuominen, RK | 1 |
| Bezard, E; Xie, YX; Zhao, BL | 1 |
| Duty, S; Mitchell, SN; O'Neill, MJ; Visanji, NP | 1 |
| Duty, S; O'Neill, MJ; Visanji, NP | 1 |
| Abin-Carriquiry, JA; Costa, G; Dajas, F; Ferreira, M; Urbanavicius, J; Wonnacott, S | 1 |
| Bellinger, LL; Guan, G; Kramer, PR; Wellman, PJ | 1 |
| Huang, LZ; Quik, M; Riveles, K | 1 |
| Christopher, NC; Eddins, D; Hampton, DS; Horton, K; Johnson, M; Levin, ED; Petro, A; Rezvani, AH; Slade, S | 1 |
| Abin-Carriquiry, JA; Cassels, BK; Costa, G; Dajas, F; Rebolledo-Fuentes, M; Urbanavicius, J; Wonnacott, S | 1 |
| Baharnouri, G; Clarke, PB; McQuade, LE; Sellings, LH | 1 |
| Bordia, T; Huang, LZ; Michael McIntosh, J; Parameswaran, N; Quik, M | 1 |
| Shimohama, S | 1 |
| Da Cunha, C; Ferro, MM; Gregório, ML; Silveira, JL; Vital, MA; Wietzikoski, EC | 1 |
| Ben-Ari, Y; Dehorter, N; Eusebio, A; Guigoni, C; Hammond, C; Hirsch, J; Lopez, C | 1 |
| Grady, SR; Huang, LZ; Quik, M | 1 |
| Ciobica, A; Hritcu, L; Padurariu, M | 1 |
| Bargas, J; Boronat-García, A; Drucker-Colín, R; García-Montes, JR; Guerra-Crespo, M; López-Colomé, AM | 1 |
| Bordia, T; Drenan, RM; McGregor, M; McIntosh, JM; Quik, M | 1 |
| Haining, RL; Hernandez, A; Jones, TM | 1 |
| Fu-Rong, H; Hai, W | 1 |
| Asadi-Shekaari, M; Eftekhar-Vaghefi, SH; Elyasi, L; Esmaeili-Mahani, S | 1 |
| Achat-Mendes, C; Fink, J; Haining, RL; Pathak, H; Smith, J | 1 |
| Clark, JD; Guo, TZ; Kingery, WS; Li, WW; Sahbaie, P; Shi, XY | 1 |
2 review(s) available for nicotine and oxidopamine
| Article | Year |
|---|---|
Involvement of nicotinic acetylcholine receptors in the protection of dopamine terminals in experimental parkinsonism.
Topics: Animals; Cytoprotection; Dopamine; In Vitro Techniques; Nerve Endings; Neuroprotective Agents; Neurotoxins; Nicotine; Oxidopamine; Parkinsonian Disorders; Receptors, Nicotinic | 2001 |
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Animals; Drug Synergism; Galantamine; Glutamic Acid; Motor Neurons; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinson Disease, Secondary; Phosphatidylinositol 3-Kinases; Rats; Receptors, Nicotinic; Rotenone; Signal Transduction; Spinal Cord | 2009 |
1 trial(s) available for nicotine and oxidopamine
| Article | Year |
|---|---|
6-OHDA lesions of the nucleus accumbens accentuate memory deficits in animals with lesions to the forebrain cholinergic projection system: effects of nicotine administration on learning and memory in the water maze.
Topics: Animals; Choline O-Acetyltransferase; Dopamine; Hippocampus; Learning; Male; Memory; Memory Disorders; Nicotine; Nucleus Accumbens; Oxidopamine; Prosencephalon; Rats; Rats, Sprague-Dawley | 1996 |
49 other study(ies) available for nicotine and oxidopamine
| Article | Year |
|---|---|
The role of the fourth cerebroventricle in nicotine-stimulated prolactin release in the rat: involvement of catecholamines.
Topics: Animals; Benzylamines; Catecholamines; Cerebral Ventricles; Male; Nicotine; Oxidopamine; Prolactin; Rats; Receptors, Adrenergic | 1992 |
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine.
Topics: Animals; Brain Chemistry; Chlorisondamine; Conditioning, Operant; Dopamine; Limbic System; Male; Nicotine; Oxidopamine; Rats; Reinforcement Schedule; Reinforcement, Psychology; Self Administration; Stereotaxic Techniques | 1992 |
Effect of nicotine on dopaminergic-cholinergic interaction in the striatum.
Topics: Acetylcholine; Animals; Corpus Striatum; Dendrites; Dopamine; Electric Stimulation; In Vitro Techniques; Interneurons; Male; Nicotine; Oxidopamine; Parasympathetic Nervous System; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Sulpiride; Sympathectomy, Chemical | 1991 |
Importance of catecholamine release for the functional action of intrastriatal implants of adrenal medullary cells: pharmacological analysis and in vivo electrochemistry.
Topics: Adrenal Medulla; Amphetamine; Animals; Apomorphine; Catecholamines; Chromaffin System; Corpus Striatum; Denervation; Dopamine; Electrochemistry; Hydroxydopamines; Immunohistochemistry; Male; Motor Activity; Nicotine; Oxidopamine; Pimozide; Rats; Rats, Inbred Strains; Transplantation, Heterotopic | 1990 |
Nicotine-induced catecholamine synthesis after lesions to the dorsal or ventral noradrenergic bundle.
Topics: Animals; Brain Chemistry; Catecholamines; Chromatography, High Pressure Liquid; Hippocampus; Hydroxydopamines; Hypothalamus; Locus Coeruleus; Male; Nicotine; Norepinephrine; Nucleus Accumbens; Oxidopamine; Rats; Rats, Inbred Strains; Sympathectomy, Chemical | 1990 |
Catecholamines mediate nicotine-induced adrenocorticotropin secretion via alpha-adrenergic receptors.
Topics: Adrenocorticotropic Hormone; Animals; Benzylamines; Brain; Brain Stem; Catecholamines; Hydroxydopamines; Isoquinolines; Male; Nicotine; Norepinephrine; Oxidopamine; Prazosin; Rats; Receptors, Adrenergic, alpha; Tetrahydroisoquinolines; Yohimbine | 1990 |
The role of calcium channel in the effect of nicotine on contractility in isolated toad ventricle.
Topics: Action Potentials; Animals; Bretylium Compounds; Bufonidae; Calcium Channel Blockers; Hydroxydopamines; In Vitro Techniques; Ion Channels; Isoproterenol; Myocardial Contraction; Nicotine; Oxidopamine; Tyramine | 1987 |
Nicotine-induced convulsions in cats and central nicotinic receptors.
Topics: 5,6-Dihydroxytryptamine; Animals; Brain; Cats; Dopamine Antagonists; Female; Ganglionic Blockers; Hemicholinium 3; Hydroxydopamines; Injections, Intraventricular; Male; Nicotine; Oxidopamine; Parasympatholytics; Receptors, Nicotinic; Reserpine; Seizures; Serotonin Antagonists; Sympatholytics | 1986 |
Pressor response mediated via histamine H1-receptors of the guinea-pig sympathetic ganglia.
Topics: Animals; Atropine; Blood Pressure; Bretylium Tosylate; Dimethylphenylpiperazinium Iodide; Female; Ganglia, Sympathetic; Guinea Pigs; Hexamethonium; Hexamethonium Compounds; Histamine; Hydroxydopamines; Male; Metiamide; Nicotine; Oxidopamine; Pyrilamine; Receptors, Histamine H1; Reserpine | 1988 |
Effects of nicotine on spontaneous contractions of isolated atria of toad (Bufo melanostictus).
Topics: Animals; Atropine; Bufonidae; Caffeine; Edetic Acid; Hemicholinium 3; Hexamethonium Compounds; Hydroxydopamines; In Vitro Techniques; Myocardial Contraction; Nicotine; Oxidopamine; Physostigmine; Tyramine; Verapamil | 1987 |
Acetylcholine releases ATP from varicosities isolated from guinea pig myenteric plexus.
Topics: Acetylcholine; Adenosine Triphosphate; Animals; Female; Guinea Pigs; Hydroxydopamines; Ileum; Male; Myenteric Plexus; Nicotine; Oxidopamine; Tetrodotoxin; Tubocurarine | 1983 |
Nonadrenergic nature of prazosin-resistant, sympathetic contraction in the dog mesenteric artery.
Topics: Animals; Cocaine; Dogs; Electric Stimulation; Female; Guanethidine; Hydroxydopamines; In Vitro Techniques; Male; Mesenteric Arteries; Nicotine; Norepinephrine; Oxidopamine; Prazosin; Quinazolines; Receptors, Adrenergic; Reserpine; Sympathetic Nervous System; Tetrodotoxin; Tyramine; Vasoconstriction | 1984 |
Multiple mechanisms for the effects of capsaicin, bradykinin and nicotine on CGRP release from tracheal afferent nerves: role of prostaglandins, sympathetic nerves and mast cells.
Topics: Animals; Bradykinin; Calcitonin Gene-Related Peptide; Capsaicin; Indomethacin; Male; Mast Cells; Neurons, Afferent; Nicotine; Oxidopamine; p-Methoxy-N-methylphenethylamine; Prostaglandins; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System; Trachea | 1994 |
Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the rat.
Topics: Animals; Dopamine; Male; Motor Activity; Neurons; Nicotine; Norepinephrine; Nucleus Accumbens; Oxidopamine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Tegmentum Mesencephali; Time Factors | 1994 |
Chronic continuous infusion of (-)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat.
Topics: Animals; Dose-Response Relationship, Drug; Fibroblast Growth Factor 2; Immunohistochemistry; Mesencephalon; Nicotine; Oxidopamine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substantia Nigra | 1996 |
Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats.
Topics: Adrenergic Agents; Adrenergic beta-Antagonists; Animals; Carteolol; Dimethylphenylpiperazinium Iodide; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Injections, Intraperitoneal; Injections, Spinal; Injections, Subcutaneous; Male; Mecamylamine; Metoprolol; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oxidopamine; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2; Receptors, Nicotinic; Tail; Tremor | 1997 |
Modulation of apomorphine-induced rotations in unilaterally 6-hydroxydopamine lesioned rats by cholinergic agonists and antagonists.
Topics: Animals; Apomorphine; Atropine; Behavior, Animal; Cholinergic Agonists; Cholinergic Antagonists; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Oxidopamine; Oxotremorine; Rats; Rats, Wistar; Sulpiride | 1997 |
Mechanism of nicotine-induced relaxation in the porcine basilar artery.
Topics: Animals; Basilar Artery; Catecholamines; Cerebrovascular Circulation; Electric Stimulation; Female; Guanethidine; In Vitro Techniques; Male; Nicotine; Nitroarginine; Oxidopamine; Swine; Vasodilation; Vasomotor System | 1998 |
Involvement of the central catecholaminergic system in nicotine-induced tail-tremor in rats.
Topics: Animals; Brain; Brain Chemistry; Catecholamines; Drug Administration Schedule; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Male; Nicotine; Oxidopamine; Rats; Rats, Wistar; Tail; Tremor | 1998 |
Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats.
Topics: Amphetamine; Animals; Autoradiography; Carrier Proteins; Caudate Nucleus; Cocaine; Denervation; Dopamine; Dopamine Plasma Membrane Transport Proteins; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Nerve Tissue Proteins; Neurons; Nicotine; Nucleus Accumbens; Oxidopamine; Putamen; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Scopolamine; Tegmentum Mesencephali; Time Factors | 1998 |
Sympathectomy inhibits the vasoactive effects of nicotine in conscious rats.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Dose-Response Relationship, Drug; Ganglionic Stimulants; Heart; Heart Rate; Hemodynamics; Male; Nicotine; Oxidopamine; Phenoxybenzamine; Rats; Rats, Inbred WKY; Sympathectomy, Chemical; Sympatholytics | 1999 |
Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: neuropharmacological characterization.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acid Transport System X-AG; Animals; Aspartic Acid; ATP-Binding Cassette Transporters; Biological Transport; Denervation; Dicarboxylic Acids; Dopamine; Extracellular Space; Glutamic Acid; Haloperidol; Kainic Acid; Kinetics; Male; Mecamylamine; Microdialysis; Neurotransmitter Uptake Inhibitors; Nicotine; Nucleus Accumbens; Oxidopamine; Pyrrolidines; Rats; Rats, Sprague-Dawley | 2000 |
Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chlorisondamine; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Injections, Subcutaneous; Male; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra | 2001 |
Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats.
Topics: Adrenergic Agents; Animals; Dextroamphetamine; Dopamine; Dopamine Uptake Inhibitors; Male; Motor Activity; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley | 2001 |
Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Corpus Striatum; Drug Administration Schedule; Drug Antagonism; Extracellular Space; Glutamic Acid; Immunohistochemistry; Male; Microdialysis; Microscopy, Electron; Motor Activity; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Synapses | 2002 |
Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Corpus Striatum; Cotinine; Disease Models, Animal; Drug Interactions; Female; Male; Neurotoxicity Syndromes; Nicotine; Nicotinic Agonists; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley | 2002 |
Locomotor stimulant effects of nornicotine: role of dopamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Drug Synergism; Male; Motor Activity; Nicotine; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Salicylamides; Stimulation, Chemical; Sympathectomy, Chemical; Sympatholytics | 2002 |
Comparison of the effects of nicotine and epibatidine given in combination with nomifensine on rotational behaviour in rats.
Topics: Adrenergic Agents; Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Male; Motor Activity; Nicotine; Nicotinic Agonists; Nomifensine; Oxidopamine; Parkinsonian Disorders; Pyridines; Rats; Rats, Wistar | 2005 |
Investigating the receptor-independent neuroprotective mechanisms of nicotine in mitochondria.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Binding Sites; Blotting, Western; Brain; Calcium; Cell Line; Cell Line, Tumor; Cytochromes c; Dose-Response Relationship, Drug; Electrons; Free Radicals; Green Fluorescent Proteins; Humans; Hydrogen Peroxide; Intracellular Membranes; Male; Membrane Potentials; Microscopy, Confocal; Mitochondria; Mitochondrial Swelling; Nicotine; Oxidopamine; Oxygen; Permeability; Plasmids; Rats; Rats, Sprague-Dawley; Spectrophotometry; Time Factors | 2005 |
Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and alpha6 and beta3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat.
Topics: Animals; Autoradiography; Dopamine; In Situ Hybridization; Male; Microdialysis; Nicotine; Nicotinic Agonists; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; RNA, Messenger; Substantia Nigra; Sympathectomy, Chemical; Sympatholytics | 2006 |
Nicotine, but neither the alpha4beta2 ligand RJR2403 nor an alpha7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle.
Topics: Analysis of Variance; Anesthetics, Inhalation; Animals; Brain Injuries; Cell Count; Dose-Response Relationship, Drug; Drug Interactions; Ethers; Hydrocarbons, Fluorinated; Immunohistochemistry; Male; Medial Forebrain Bundle; Nicotine; Nicotinic Agonists; Oxidopamine; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2006 |
Nicotine induces tyrosine hydroxylase plasticity in the neurodegenerating striatum.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Axons; Corpus Striatum; Denervation; Dopamine; Down-Regulation; Levodopa; Male; Nerve Degeneration; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2007 |
Nicotine's attenuation of body weight involves the perifornical hypothalamus.
Topics: Animals; Body Weight; Catecholamines; Eating; Epinephrine; Hypothalamus; Male; Nicotine; Nicotinic Agonists; Norepinephrine; Oxidopamine; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical; Sympatholytics | 2007 |
Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Catecholamines; Cell Count; Cell Differentiation; Cell Line; Cell Survival; Cotinine; Humans; Immunohistochemistry; Neuroprotective Agents; Nicotiana; Nicotine; Nicotinic Agonists; Oxidopamine; Phenotype; Pyridines; Receptors, Nicotinic; Smoke; Smoking; Tyrosine 3-Monooxygenase | 2008 |
Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administration.
Topics: Animals; Animals, Newborn; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine; Female; Learning; Male; Maze Learning; Memory; Motor Activity; Nicotine; Nicotinic Agonists; Norepinephrine; Oxidopamine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Self Administration; Serotonin; Sympathectomy, Chemical; Sympatholytics; Tobacco Use Disorder | 2008 |
In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson's Disease.
Topics: Alkaloids; Animals; Antiparkinson Agents; Azocines; Bridged-Ring Compounds; Disease Models, Animal; Dopamine; Male; Microdialysis; Neostriatum; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinsonian Disorders; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Receptors, Presynaptic; Substantia Nigra | 2008 |
Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens.
Topics: Animals; Avoidance Learning; Choice Behavior; Conditioning, Psychological; Dopamine; Injections, Intravenous; Injections, Subcutaneous; Male; Nicotine; Nucleus Accumbens; Oxidopamine; Rats; Rats, Long-Evans; Reward; Spatial Behavior; Synaptic Transmission; Taste | 2008 |
Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Analysis of Variance; Animals; Autoradiography; Cocaine; Conotoxins; Corpus Striatum; Cotinine; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Iodine Isotopes; Male; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Nicotine; Oxidopamine; Protein Binding; Rats; Rats, Sprague-Dawley; Saimiri; Substantia Nigra; Time Factors | 2009 |
Nicotine induces sensitization of turning behavior in 6-hydroxydopamine lesioned rats.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Electrochemistry; Functional Laterality; Ganglionic Stimulants; Male; Nicotine; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Time Factors | 2009 |
Dopamine-deprived striatal GABAergic interneurons burst and generate repetitive gigantic IPSCs in medium spiny neurons.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Adrenergic Agents; Animals; Biological Clocks; Biophysics; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Electric Stimulation; Excitatory Amino Acid Antagonists; GABA Agents; gamma-Aminobutyric Acid; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Interneurons; Lysine; Mice; Nicotine; Nicotinic Agonists; Oxidopamine; Patch-Clamp Techniques; Spectrum Analysis; Tyrosine 3-Monooxygenase; Valine | 2009 |
Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptors.
Topics: Animals; Antiparkinson Agents; Autoradiography; Bridged Bicyclo Compounds, Heterocyclic; Corpus Striatum; Cotinine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Functional Laterality; Levodopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Nicotinic Agonists; Oxidopamine; Pyridines; Receptors, Nicotinic; Substantia Nigra; Sympatholytics | 2011 |
The effects of short-term nicotine administration on behavioral and oxidative stress deficiencies induced in a rat model of Parkinson's disease.
Topics: Adrenergic Agents; Animals; Behavior, Animal; Disease Models, Animal; Ganglionic Stimulants; Glutathione Peroxidase; Lipid Peroxidation; Male; Maze Learning; Memory, Short-Term; Nicotine; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Substantia Nigra; Temporal Lobe | 2012 |
Is nicotine protective against Parkinson's disease? An experimental analysis.
Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Interneurons; Male; Nerve Tissue Proteins; Neuroprotective Agents; Nicotine; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra | 2012 |
Evidence for a role for α6(∗) nAChRs in l-dopa-induced dyskinesias using Parkinsonian α6(∗) nAChR gain-of-function mice.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Antiparkinson Agents; Benserazide; Cocaine; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Levodopa; Male; Mice; Mice, Transgenic; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinsonian Disorders; Protein Binding; Receptors, Nicotinic | 2015 |
Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.
Topics: Caffeine; Cysteine; Dopamine; Iron; Melanins; Nicotine; Oxidopamine; Parkinson Disease; Polymerization; Spectrometry, Fluorescence | 2016 |
[Modulation by desensitized nicotinic receptors on metabolism of DA in striatum derived from the hemiparkinsonian model].
Topics: Animals; Corpus Striatum; Dopamine; Monoamine Oxidase; Nicotine; Oxidopamine; Parkinsonian Disorders; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Nicotinic | 2016 |
Induction of cross-tolerance between protective effect of morphine and nicotine in 6-hydroxydopamine-induce neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Dopaminergic Neurons; Drug Tolerance; Humans; Morphine; Neuroprotective Agents; Nicotine; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Reactive Oxygen Species | 2019 |
Development of a Competition-Binding Assay to Determine Binding Affinity of Molecules to Neuromelanin via Fluorescence Spectroscopy.
Topics: Animals; Binding, Competitive; Biological Assay; Catecholamines; Cells, Cultured; Humans; Melanins; Nicotine; Oxidation-Reduction; Oxidopamine; Polymerization; Rats; Signal Transduction; Spectrometry, Fluorescence | 2019 |
Autonomic Regulation of Nociceptive and Immunologic Changes in a Mouse Model of Complex Regional Pain Syndrome.
Topics: Animals; Autonomic Nervous System; Chronic Pain; Complex Regional Pain Syndromes; Disease Models, Animal; Fractures, Bone; Hypertrophy; Immunoglobulin M; Mice; Nicotine; Nociception; Oxidopamine | 2022 |